Transplantation Reports · Published 2024-11-19 · DOI 10.1016/j.tpr.2024.100164
The proportion of elderly lung transplant recipients has increased substantially in recent years. The immunosuppressants required significantly increase the risk for infection and malignancy in the elderly population. However, there is a paucity of data on immunosuppression management practices in this group. Herein, we report results of the first national aggregation of immunosuppressant strategies in elderly lung transplant recipients within the US.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →